Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

766 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Paragonimiasis and pulmonary tuberculosis].
Añaños G, Trilla A, Graus F, Mas J, Corachán M, Soriano E. Añaños G, et al. Among authors: mas j. Med Clin (Barc). 1992 Feb 22;98(7):257-9. Med Clin (Barc). 1992. PMID: 1560702 Spanish.
[Report of 72 cases of imported malaria].
Corachán M, Mas J, Gascón J, Valls ME. Corachán M, et al. Among authors: mas j. Rev Clin Esp. 1989 May;184(8):448-9. Rev Clin Esp. 1989. PMID: 2535676 Spanish. No abstract available.
[The irresistible rise of malaria in Spain].
Racaj J, Ruiz L, Corachan M, Mas J. Racaj J, et al. Among authors: mas j. Rev Clin Esp. 1988 Mar;182(4):239-41. Rev Clin Esp. 1988. PMID: 3413319 Spanish. No abstract available.
Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence.
Romeo-Guitart D, Forés J, Herrando-Grabulosa M, Valls R, Leiva-Rodríguez T, Galea E, González-Pérez F, Navarro X, Petegnief V, Bosch A, Coma M, Mas JM, Casas C. Romeo-Guitart D, et al. Among authors: mas jm. Sci Rep. 2018 Jan 30;8(1):1879. doi: 10.1038/s41598-018-19767-3. Sci Rep. 2018. PMID: 29382857 Free PMC article.
In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm.
Artigas L, Coma M, Matos-Filipe P, Aguirre-Plans J, Farrés J, Valls R, Fernandez-Fuentes N, de la Haba-Rodriguez J, Olvera A, Barbera J, Morales R, Oliva B, Mas JM. Artigas L, et al. Among authors: mas jm. PLoS One. 2020 Oct 2;15(10):e0240149. doi: 10.1371/journal.pone.0240149. eCollection 2020. PLoS One. 2020. PMID: 33006999 Free PMC article.
766 results